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Barrier Function of the Cell
Membrane
The cell membrane separates the inte-
rior of the cell from the outside and regu-
lates the molecular and ionic content of the
intracellular medium. The majority of the
energy required to sustain cellular func-
tion is expended in maintaining large dif-
ferences in ion concentrations across the
cell membrane. The lipid bilayer provides
the ionic diffusion barrier that makes it
energetically possible to maintain large
transmembrane ion concentration gradi-
ents. The bilayer serves this role remark-
ably well by establishing a nonpolar region
through which an ion must pass in order
to cross the membrane. The high energy
needed for such a passage is a strong im-
pediment to passive ion diffusion across
the bilayer.1 However, cell membranes con-
sist typically of 30% protein; many of these
proteins facilitate and regulate membrane
ion transport. Roughly, these protein ef-
fects combine to make the cell membrane
approximately 106 times more conductive
to ions than the pure lipid bilayer.2
The cell membrane is in essence a two-
dimensional structured fluid, held intact
only by van der Waals, hydrophobic,
hydrogen-bonding, and screened electro-
static interactions. Occasionally, small sepa-
rations in the lipid packing order occur,
producing transient structural defects with
lifetimes on the order of nanoseconds. The
lifetime and size of these transient pores
are influenced by external factors such as
temperature and electric field strength.
Loss of Membrane Integrity
Many forms of trauma can disrupt the
barrier function of the cell membrane. Loss
of membrane integrity occurs in tissues at
supraphysiologic temperatures (i.e., ther-
mal burns), with very intense ionizing
radiation exposure, in frostbite, in baro-
metric trauma, and with exposure to strong
electrical forces. Resuscitated victims of
major trauma often experience ischemia-
reperfusion injury in which the integrity
of the cell membrane is compromised due
to oxidative damage to the membrane
lipids.3 Reactive-oxygen-mediated mem-
brane breakdown is the mechanism of
acute necrosis induced by high-dose radi-
ation.4 Under freezing conditions, ice nu-
cleation can lead to mechanical disruption
of the membrane,5 while sudden changes
in very strong barometric pressures can re-
sult in acoustic disruption of the mem-
brane. Electrical shock is the paradigm for
necrosis mediated primarily by mem-
brane permeabilization.
The ability of an electric field to disrupt
membrane integrity has been exploited
for the delivery of genes and drugs.6–8 The
first demonstration of gene transfer into
rat cells using electroporation was made
in 1982,9 and the first clinical study on the
use of electroporation to increase uptake
of a chemotherapeutic agent in tumors
was reported in 1993.10 As in the case of
electric-shock trauma, electroporation
occurs when an applied external field ex-
ceeds the capacitance of the cell membrane.
This leads to the formation of what one
hopes will be transient pores, allowing the
cell to be loaded with different types of
molecules, from radiotracers11 and drugs12,13
to RNA14 and DNA,9,15 through either sim-
ple diffusion or electrophoretically driven
processes. Depending on the particular
cell type and the type of molecule to be de-
livered, some systems require the use of
high electric fields and/or long pulses to
achieve reasonable loading yield, but at
the expense of survivability of the cell due
to the inability of the membrane to reseal.
Under these scenarios, ion pumps can-
not keep pace with the increased diffusion
of ions across the membrane. As a result,
the cell’s metabolic energy is quickly ex-
hausted, leading to biochemical arrest and
necrosis. Defects formed in the membrane
can be further stabilized by membrane
proteins anchored in the intra- or extra-
cellular space. Chang and Reese16 have
demonstrated that stable defects—“pores”
in the range of 0.1 μm––occur in electro-
porated membranes. In other cases, the
translateral motion of lipids, normally re-
stricted by anchored proteins, may cause
the membrane to bleb, or form a sac-like
structure that protrudes towards the extra-
cellular space, due to the expansion of
electroporated membranes. This compro-
mises the local lipid packing and leads to
enhanced permeability.
While trauma-induced membrane per-
meabilization and disruption constitute a
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An intact cell membrane serves as a permeable barrier, regulating the influx and
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cause of tissue injury, the same process
can be used therapeutically for effective
gene and drug delivery. The commonality
between the two suggests that the rescue
of cells whose membranes are structurally
damaged in the case of trauma, and 
the enhancement of cell survival in
electroporation-mediated gene and drug
delivery, can be achieved by the design
and administration of a biomaterial capa-
ble of sealing structurally compromised
membranes.
Surfactant Sealing of Cell
Membranes
Under normal circumstances, fusogenic
proteins, which are capable of fusing lipid
membranes together, induce membrane
sealing following exocytosis, the process
whereby intracellular materials are trans-
ported to the extracellular space by the
formation of vesicles and by vesicles
pinching off the cellular membrane. This
is done by creating a low-energy pathway
for phospholipids to flow across the defect
or to induce fusion of transport vesicles to
plasma membranes. When the cell is sub-
jected to insults like electric shock, this
normal pathway may be compromised
and the natural sealing process can be im-
peded. It has been demonstrated that
membrane sealing can be accomplished
by surfactants such as poloxamers and
poloxamines. Poloxamers and poloxam-
ines belong to a class of water-soluble tri-
block copolymers often abbreviated as
PEO-PPO-PEO, with PEO and PPO repre-
senting poly(ethylene oxide) and poly-
(propylene oxide), respectively. The PEO
chains are hydrophilic, due to their short
carbon unit between the oxygen bridges,
whereas the PPO center is hydrophobic,
due to the larger propylene unit (see
Structure 1). Commercially available
poloxamers and poloxamines have both
PEO chains of similar length in a particular
copolymer. The lengths of the hydrophilic
and the hydrophobic chains and their
length ratios can vary tremendously, form-
ing a large group of copolymers widely
used in industrial applications as emulsi-
fying, wetting, coating, stabilizing, lubricat-
ing, and foaming agents.17 The poloxamer
series covers a range of liquids, pastes,
and solids, with molecular weights vary-
ing from 1100 to about 14,000. The polox-
amine series is slightly different from the
poloxamer series in that the hydrophobic
center consists of two tertiary amino groups
each carrying two PPO chains of equal
length and each followed by a PEO chain.
It is therefore much bulkier than poloxamer.
Poloxamer 188 (P188) has been widely
used in medical applications since 1957,
mainly as an emulsifier and anti-sludge
agent in blood.18 P188 has an average mo-
lecular weight of about 8400 and is pre-
pared from a 1750 average molecular
weight hydrophobe (the first two num-
bers in P188 reflect the 1.8 kDa molecular
weight of this unit), and its hydrophile
comprises about 80% (reflected in the last
digit, 8) of the total molecular weight. Thus,
most investigations on the sealing capabil-
ities of surfactants have focused on P188
because of its established medical safety
record.
The first demonstration of sealing
showed that P188 could prevent cells from
losing carboxyfluorescein dye after electro-
poration.19 Low-molecular-weight (10 kDa)
neutral dextran was unsuccessful in pro-
ducing the same effect. P188 can seal
membrane pores in skeletal muscle cells
after heat shock20 and enhance the func-
tional recovery of lethally heat-shocked
fibroblasts.21 P188 was also shown to pro-
tect against glutamate toxicity in rat brain
cells,22 protect embryonic hippocampal
neurons against death due to neurotoxic-
induced loss of membrane integrity,23,24
and reduce the leakage of normally
membrane-impermeant calcein dye as
well as prevent acute necrosis in high-
dose-irradiated muscle cells.4,25 Poloxamine
1107 (P1107), with two hydrophilic blocks
linked to the central hydrophobic block on
each side, has been shown to reduce testi-
cular ischemia-reperfusion injury,26 hemo-
globin leakage from red blood cells after
ionizing radiation,27 and propidium iodine
uptake of white blood cells after high-dose
ionizing irradiation.28 In all of these cases,
the observed phenomena have been at-
tributed to surfactant sealing of permeabi-
lized membranes. The effect of P188
infusions in reducing the duration and
severity of acute painful episodes of sickle
cell disease is currently explained by ben-
eficial surfactant–erythrocyte membrane
interactions.29 Other poloxamers have
been shown to increase the uptake of can-
cer drugs into tumor cells.30
Surfactant–Lipid Interactions
This class of triblock copolymers clearly
constitutes an effective biomaterial for
membrane sealing. Elucidation of the mech-
anism by which these polymers help seal
damaged membranes should aid the de-
sign of suitable polymers for therapeutic
purposes. From a design point of view, an
ideal sealant should selectively interact
with damaged membranes without inter-
fering with intact ones. Moreover, when
the membrane structural integrity is re-
stored, there should be an exit mechanism
in place for the polymer to depart from the
membrane so as not to interfere with the
cell healing process. As the native cell
membrane is complex, model lipid systems
provide excellent platforms for elucidating
the molecular mechanism of membrane
sealing.
Insertion of Poloxamers into
Membranes with Compromised
Lipid Packing Density31
Although a monolayer at the air–water
interface represents only one of the two
lipid monolayers, or leaflets, that make up
a lipid bilayer, using it to mimic the outer
leaflet of the cell membrane provides an
effective way to assess how various attrib-
utes of the lipid and the copolymer sur-
factant can affect their interactions. For an
intact membrane, the lipids are packed in
a way similar to the lipid packing found in
a monolayer at about 30 mN/m. Using an
insertion assay, where a lipid monolayer is
compressed to the bilayer equivalent pres-
sure and the pressure is held constant via
a feedback mechanism, we monitor the as-
sociation of poloxamer with the lipid film.
If the poloxamer inserts into the mono-
layer, the surface pressure will increase; in
order to hold the pressure constant, the
area has to increase to reverse the effect.
Likewise, if poloxamer desorbs from the
surface, the surface pressure will drop; an
effort to maintain constant surface pres-
sure therefore results in the decrease of the
surface area.
At the bilayer equivalent pressure, no
insertion is observable for either zwitteri-
onic dipalmitoyl phosphatidylcholine
(DPPC) or anionic dipalmitoyl phospha-
tidylglycerol (DPPG) monolayers.31 The
loss of membrane integrity is mimicked
by systematically lowering the lipid pack-
ing density (reducing the surface pressure
by 2 mN/m at a time). No sign of inser-
tion is observed until the threshold sur-
face pressure of 24 mN/m is reached,31
at which point the change in area per
molecule (indicative of insertion) is small
but significant. When the surface pressure
is further reduced to 22 mN/m, there is
rapid insertion of P188 into both monolay-
ers.31 Figure 1 shows such an insertion
isotherm for DPPC; the insertion isotherm
for DPPG looks similar. Together, these re-
Structure 1. Chemical structure of
poloxamers. The series of different
poloxamers is constituted through
varying numbers and ratios for a and b.
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sults suggest that P188 only interacts with
compromised membranes where the local
lipid packing density is reduced, and does
not non-specifically insert into membranes
whose lipid packing is intact.31 Moreover,
as similar injection results are obtained for
DPPC and DPPG monolayers, poloxamer
insertion is not influenced by the electro-
statics of the lipid head group.31 Insertion
assays using unsaturated zwitterionic di-
oleoyl phosphatidylcholine (DOPC) show
similar results (see Figure 1), except that
insertion occurs at a slightly higher surface
pressure, likely arising from the looser
packing of the acyl chains in the unsatu-
rated lipid.
“Squeeze-Out” of Poloxamer upon
Restoration of Membrane Structural
Integrity
With the poloxamer inserted into the
structurally compromised membrane,
what then is the fate of the polymer when
the membrane integrity is reestablished
(e.g., by cell healing processes)? To address
this, we compare compression isotherms
for a pure DPPG monolayer, a DPPG
monolayer pretreated with 50 μL of P188,
and another DPPG monolayer pretreated
with 200 μL of P188.31,32 In the pretreated
cases, the lipid monolayer is spread at a
low surface density, and the polymer is in-
troduced to the subphase when the sur-
face pressure π  0 mN/m. In both
P188-pretreated cases, the surface pressure
rises from 0 mN/m to around 20 mN/m
upon administration of the poloxamer.
The three isotherms, however, are essen-
tially identical when the surface pressure
of 26 mN/m is reached (Figure 2). This
suggests that at higher surface pressure
(or tighter packing density), P188 is
“squeezed out” of (i.e., excluded from) the
film. As the polymer leaves the lipid film,
forming most likely micellar structures in
the water subphase, the monolayer is left
with almost purely DPPG molecules.31,32
X-ray reflectivity data for lipid monolay-
ers with or without P188 in the subphase
show identical reflectivity curves at high
pressures, further corroborating the
“squeeze-out” of P188.33,34 This interesting
phenomenon points to the ability of the
cell to eliminate the poloxamer sealant
after the normal membrane lipid packing
density is regained.
Lipid Corralling by Poloxamers
The immediate increase in the surface
pressure from 0 mN/m to 20 mN/m upon
the introduction of P188 in the subphase
(see Figure 2) indicates the surface activity
of the polymer.31 By physically occupying
part of the surface area, the adsorbed
poloxamers leave the lipid molecules a
smaller surface area to span, and hence
help tighten their packing. This tightening
of the lipid packing by poloxamer inser-
tion is further confirmed using grazing in-
cidence x-ray diffraction. Figure 3 shows
that Bragg peaks, signifying lipid order-
ing, are present at a much larger nominal
lipid area when P188 is present in the
subphase.33,34
Tunability of Poloxamer Insertion
Capability
With the three blocks constituting the
poloxamer, its ability to insert into mem-
branes can be tuned by varying the num-
ber of monomers in each block. To test
whether the size of the PPO subunit regu-
lates the polymer’s insertion capabilities,
we have investigated the effect of sister
poloxamers P108, P238, and P338 with
identical PPO/PEO weight percentages
but different overall molecular weights.35
While the higher-molecular-weight poloxa-
mers have a larger number of PPO sub-
units, the bulkiness of the hydrophobic
block limits their ability to insert into the
lipid monolayer. Once inserted, however,
their large hydrophobic subunits help them
maintain their positions in the mono-
layer.35 Together, these results suggest that
Figure 1. Step-down curves for
dipalmitoyl phosphatidylcholine (DPPC)
(blue curve) and dioleoyl phospha-
tidylcholine (DOPC) (magenta curve)
monolayers in the presence of
Polaxamer 188 (P188). Monolayer films
were compressed to 30 mN/m before
P188 was injected into the subphase.
As no changes in the area per molecule
were observed at 30 mN/m after
10 min, the pressure was lowered by
2 mN/m and held at the reduced
pressure for 10 min to allow for insertion.
This surface-pressure-lowering
procedure was continued until insertion
was noted. P188 inserts into the lipid
films below a critical surface pressure,
and the critical pressure for DOPC is
higher than that for DPPC.31,32
Figure 2. Isotherms of pure DPPG (blue
curve); DPPG pretreated with 50 μL of
P188 (magenta curve); and
DPPG pretreated with 200 μL of
P188 (green curve).31,32 DPPG is
dipalmitoyl phosphatidylglycerol. The
films were spread at a high area per
molecule. For the P188-treated
systems, the polymer was injected into
the subphase. The surface activity of
the polymer resulted in a rise of the
surface pressure from 0 mN/m to
20 mN/m upon its introduction into
the subphase. When the films were
compressed to surface pressures of
25 mN/m and greater, the isotherm of
the P188-treated systems overlapped
with that of the pure lipid, indicating
that P188 is “squeezed out” of the film
at surface pressures equal to 25 mN/m
or greater.
Figure 3. Bragg peaks from grazing
incidence x-ray diffraction on water at
30°C for (a) DPPC and (b) DPPC/P188.
The presence of the polymer forces the
lipids to pack more tightly.33,34
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the energy barrier for poloxamer insertion
is different from that for poloxamer
squeeze-out. Increasing the hydrophobic:
hydrophilic ratio while keeping the over-
all molecular weight constant, on the
other hand, enhances the poloxamer’s
ability to insert into lipid membranes.
Conclusion
Poloxamer has the ability to insert into
the damaged region of a membrane where
the local lipid-packing density is reduced.
By doing so, it helps increase the local
packing density and thus re-establish the
barrier function of the membrane. The in-
capability of the poloxamer to remain in
the lipid film when the normal bilayer
packing density is restored provides a
graceful exit mechanism for the polymer.
The results discussed here are only the
first step toward understanding lipid/
poloxamer interactions in the context of
membrane sealing. Many questions re-
garding the molecular mechanism of this
sealing action remain largely unknown. A
thorough understanding of the structure–
activity relations of these polymers is
clearly needed in order to better design
and develop them as sealing agents. Not
only will these engineered copolymers be
important materials for therapeutic treat-
ment in medical trauma, they will also be
beneficial for improving cell survivability
in the delivery of genes or drugs into cells
using electroporation.
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